Josefa Terrasa

6.2k total citations
31 papers, 420 citations indexed

About

Josefa Terrasa is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Josefa Terrasa has authored 31 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Surgery. Recurrent topics in Josefa Terrasa's work include Testicular diseases and treatments (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (8 papers). Josefa Terrasa is often cited by papers focused on Testicular diseases and treatments (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (8 papers). Josefa Terrasa collaborates with scholars based in Spain, Palestinian Territory and Switzerland. Josefa Terrasa's co-authors include Juli Rifà, Magdalena Esteva, Joan Llobera, Enric Benito, Gustavo Catalán, Javier Martín‐Broto, Ignacio Durán, Jorge Aparicio, Pablo Maroto and Xavier García del Muro and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Josefa Terrasa

29 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josefa Terrasa Spain 11 154 116 102 88 86 31 420
Christopher Kingswood United Kingdom 8 122 0.8× 153 1.3× 38 0.4× 338 3.8× 83 1.0× 15 824
Mikkel Bandak Denmark 16 542 3.5× 111 1.0× 44 0.4× 150 1.7× 101 1.2× 49 733
I. N. Olver Australia 11 171 1.1× 242 2.1× 49 0.5× 107 1.2× 16 0.2× 17 504
Merete Kjær Hansen Denmark 11 160 1.0× 50 0.4× 53 0.5× 74 0.8× 30 0.3× 16 382
Arif Kökçü Türkiye 18 89 0.6× 165 1.4× 149 1.5× 46 0.5× 35 0.4× 53 822
Marios Paulides Germany 15 54 0.4× 118 1.0× 201 2.0× 183 2.1× 48 0.6× 30 629
Miranda J. Rogers United States 11 163 1.1× 63 0.5× 26 0.3× 150 1.7× 55 0.6× 36 514
T.Z. Vern-Gross United States 11 138 0.9× 95 0.8× 88 0.9× 178 2.0× 18 0.2× 40 404
Frank Forte United States 12 101 0.7× 74 0.6× 26 0.3× 67 0.8× 22 0.3× 42 400
Yoo Seok Kim South Korea 13 133 0.9× 195 1.7× 23 0.2× 91 1.0× 34 0.4× 39 558

Countries citing papers authored by Josefa Terrasa

Since Specialization
Citations

This map shows the geographic impact of Josefa Terrasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josefa Terrasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josefa Terrasa more than expected).

Fields of papers citing papers by Josefa Terrasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josefa Terrasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josefa Terrasa. The network helps show where Josefa Terrasa may publish in the future.

Co-authorship network of co-authors of Josefa Terrasa

This figure shows the co-authorship network connecting the top 25 collaborators of Josefa Terrasa. A scholar is included among the top collaborators of Josefa Terrasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josefa Terrasa. Josefa Terrasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Azkárate, Aitor, Ana Blasco, Silvia Calabuig‐Fariñas, et al.. (2020). Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR. Frontiers in Medicine. 7. 594900–594900. 15 indexed citations
3.
Maroto, Pablo, Xavier García del Muro, Claudia Valverde, et al.. (2020). Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer. Urologic Oncology Seminars and Original Investigations. 39(2). 135.e17–135.e23. 5 indexed citations
4.
Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2020). Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group. Clinical & Translational Oncology. 23(1). 58–64. 5 indexed citations
5.
Aparicio, Jorge, Alfonso Sánchez‐Muñoz, Josep Gumà, et al.. (2018). A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study. Oncology. 95(1). 8–12. 10 indexed citations
6.
Felipe‐Abrio, Irene, Silvia Calabuig‐Fariñas, Rafael Ramos, et al.. (2017). Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells. Molecular Cancer Therapeutics. 16(6). 1166–1176. 11 indexed citations
7.
González‐Billalabeitia, Enrique, Juan Manuel Sepúlveda-Sánchez, Pablo Maroto, et al.. (2016). Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer. European Urology Focus. 3(2-3). 280–286. 3 indexed citations
8.
Isla, Dolores, Enriqueta Felip, Núria Viñolas, et al.. (2016). Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07. Anticancer Research. 36(12). 6647–6654. 8 indexed citations
9.
Gironés, Regina, Jorge Aparicio, J. R. Germa-Lluch, et al.. (2014). Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base. Clinical & Translational Oncology. 16(11). 959–965. 15 indexed citations
10.
Massutí, Bartomeu, Eloísa Jantus‐Lewintre, Delvys Rodríguez‐Abreu, et al.. (2014). ANGIOMET: Analysis of the correlations between angiogenic markers and outcome in patients (p) with advanced nonsquamous NSCLC (NS-NSCLC) treated with carboplatin, paclitaxel, and bevacizumab (CPB).. Journal of Clinical Oncology. 32(15_suppl). e19014–e19014. 1 indexed citations
11.
Cantos, Blanca, Margarita Majem, Pilar Garrido, et al.. (2012). Menstrual status and lung cancer in female patients from the Spanish WORLD07 database.. Journal of Clinical Oncology. 30(15_suppl). e12012–e12012. 3 indexed citations
12.
Felip, Eudald, Pilar Garrido, Margarita Majem, et al.. (2010). Small cell lung cancer in women: The Spanish female-specific database WORLD07.. Journal of Clinical Oncology. 28(15_suppl). e12044–e12044. 1 indexed citations
13.
Isla, Dolores, Enriqueta Felip, Pilar Garrido, et al.. (2007). P2-106: Gender differences in non-small cell lung cancer (NSCLC) patients (p): A retrospective study based in Spanish Lung Cancer Group(SLCG) trials.. Journal of Thoracic Oncology. 2(8). S533–S534. 1 indexed citations
14.
Camps, Carlos, R. de las Peñas, Guillermo López-Vivanco, et al.. (2006). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small cell lung cancer: An analysis of the Spanish Lung Cancer Group pharmacogenomic study of cisplatin and docetaxel combination (PLATAX). Journal of Clinical Oncology. 24(18_suppl). 7124–7124. 2 indexed citations
15.
Aguiar, David, et al.. (2004). Toxic Epidermal Necrolysis in Patients Receiving Anticonvulsants and Cranial Irradiation: A Risk to Consider. Journal of Neuro-Oncology. 66(3). 345–350. 61 indexed citations
16.
Felip, Enriqueta, Rafael Rosell, Manuel Dómine, et al.. (2003). Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study. Annals of Oncology. 14(10). 1549–1554. 10 indexed citations
17.
Aparicio, Jorge, Xavier García del Muro, Pablo Maroto, et al.. (2003). Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Annals of Oncology. 14(6). 867–872. 78 indexed citations
18.
Muro, Xavier García del, Pablo Maroto, A. Barnadas, et al.. (2003). 884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience. European Journal of Cancer Supplements. 1(5). S266–S266. 1 indexed citations
19.
Llobera, Joan, et al.. (2003). Quality of life for oncology patients during the terminal period. Validation of the HRCA-QL index. Supportive Care in Cancer. 11(5). 294–303. 11 indexed citations
20.
Llobera, Joan, Magdalena Esteva, Juli Rifà, et al.. (2000). Terminal cancer. European Journal of Cancer. 36(16). 2036–2043. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026